A MULTICENTER PHASE 1 TRIAL OF TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER2 POSITIVE BREAST CANCER (TUTOR) Other Scholarly Work

Ahluwalia, Manmeet, Ozair, Ahmad, Bardhan, Mainak et al. (2024). A MULTICENTER PHASE 1 TRIAL OF TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER2 POSITIVE BREAST CANCER (TUTOR) . NEURO-ONCOLOGY, 26 10.1093/neuonc/noae165.0399

cited authors

  • Ahluwalia, Manmeet; Ozair, Ahmad; Bardhan, Mainak; Bellur, Shreyas; Starosciak, Amy; Perche, Dilanis; Khosla, Atulya; Leon-Ariza, Daniel; Rubens, Muni; Odia, Yazmin; Mehta, Minesh; Kotecha, Rupesh; Mcdermott, Michael; Sandoval-Leon, Ana; Mahtani, Reshma; Peereboom, David

authors

publication date

  • November 11, 2024

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • TX, Houston

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

volume

  • 26